Sonia Ponzo

Work

• Evidence-led repositioning for a consumer wellbeing app entering B2B

  • Business Strategy
  • Market Research
  • Go-to-Market Strategy

  Supported a consumer wellbeing app pivoting towards a B2B model, with limited clarity on organisational value and no established sales infrastructure. The challenge was to identify a credible organisational use case and a realistic route to market.

  Identified neurodivergent support as the strongest organisational entry point and built an evidence-led positioning aligned with employer needs. Defined…

  Show More

• Market entry and positioning strategy for a digital health company entering the US B2B market

  • Business Strategy
  • Go-to-Market Strategy

  Worked with a digital health company preparing to enter the US B2B market, initially seeking tactical content support but lacking a clear strategic buyer framework. The leadership team needed clarity on who would buy, why, and how to communicate value credibly in a new market.

  Delivered a structured strategy combining buyer priorities, public health burden data, and real user language to define pri…

  Show More

• Evidence and commercial strategy for a clinically led mental wellbeing company

  • Business Strategy
  • Research

  Supported a clinically led mental wellbeing company operating in a competitive employer market where buyers increasingly required proof of impact. The team had strong clinical credibility but lacked a clear commercial evidence narrative to support sales, renewals, and bids.

  Led the development of an evidence and outcomes strategy aligned to buyer decision-making, translating clinical insight into a…

  Show More

• De-risking market entry for a US biotech company

  • Business Strategy
  • Market Research
  • Regulatory Compliance
  • Go-to-Market Strategy

  Currently leading a feasibility and market-entry assessment for a US-based biotech company evaluating expansion into the UK. The work is designed to inform a board-level decision on whether the UK represents a viable and strategically sound next market.

  The engagement includes analysis of market demand, buyer landscape, regulatory and system-level considerations, and commercial risk factors. Outputs are structured to support executive and board discussion rather than operational execution.

  This work will directly inform a forthcoming board decision on UK market entry and investment allocation.